Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -23.11% is 76% above its 5-year average of -97.33%, near the high end of its 5-year range (-304.39%–21.19%).
86.64% above its 12-month average of -173.03%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -6.00%.
RETURN ON ASSETS (ROA)
-23.11%
RETURN ON ASSETS (ROA) AVG TTM
-173.03%
RETURN ON ASSETS (ROA) AVG 3Y
-145.25%
RETURN ON ASSETS (ROA) AVG 5Y
-97.33%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+86.64%
CURRENT VS 3Y AVG
+84.09%
CURRENT VS 5Y AVG
+76.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.18%
median of 678 covered companies
CURRENT VS SECTOR MEDIAN
+23.44%
vs the sector median at left
Healthcare Triangle, Inc.
Market Cap
$8.53M
Return on Assets (ROA)
-23.11%
TTM Avg
-173.03%
3Y Avg
-145.25%
5Y Avg
-97.33%
Market Cap
$8.30M
Return on Assets (ROA)
-269.47%
TTM Avg
-172.22%
3Y Avg
-300.06%
5Y Avg
-300.06%
Market Cap
$8.14M
Return on Assets (ROA)
-29.10%
TTM Avg
-66.56%
3Y Avg
-142.45%
5Y Avg
-115.37%
Market Cap
$8.00M
Return on Assets (ROA)
-74.50%
TTM Avg
-220.41%
3Y Avg
-182.97%
5Y Avg
-158.82%
Market Cap
$7.93M
Return on Assets (ROA)
-381.53%
TTM Avg
-330.40%
3Y Avg
-209.86%
5Y Avg
-253.27%
Market Cap
$9.17M
Return on Assets (ROA)
-157.56%
TTM Avg
-309.44%
3Y Avg
-441.71%
5Y Avg
-440.28%
Market Cap
$7.97M
Return on Assets (ROA)
N/A
TTM Avg
-103.86%
3Y Avg
-117.64%
5Y Avg
-138.14%
Market Cap
$9.21M
Return on Assets (ROA)
-6.36%
TTM Avg
-31.97%
3Y Avg
-31.64%
5Y Avg
-61.82%
Market Cap
$7.83M
Return on Assets (ROA)
-76.12%
TTM Avg
-177.28%
3Y Avg
-394.98%
5Y Avg
-300.85%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $8.53M | -23.11% | -173.03% | -145.25% | -97.33% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.30M | -269.47% | -172.22% | -300.06% | -300.06% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.14M | -29.10% | -66.56% | -142.45% | -115.37% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $8.00M | -74.50% | -220.41% | -182.97% | -158.82% |
| GT Biopharma, Inc. (GTBP)vs › | $7.93M | -381.53% | -330.40% | -209.86% | -253.27% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.17M | -157.56% | -309.44% | -441.71% | -440.28% |
| HeartSciences Inc. (HSCS)vs › | $7.97M | N/A | -103.86% | -117.64% | -138.14% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.21M | -6.36% | -31.97% | -31.64% | -61.82% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | -76.12% | -177.28% | -394.98% | -300.85% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.33M | -269.20% | -150.53% | -111.73% | -102.54% |
ROA
-23.1%
ROE
-34.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -41.68% |
| 2024-12-31 | -304.39% |
| 2023-12-31 | -126.66% |
| 2022-12-31 | -108.26% |
| 2021-12-31 | -24.17% |
| 2020-12-31 | 21.19% |
| 2019-12-31 | 14.20% |
